IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours
Guo, DL; Zhang, J; Yuen, ST; Tsui, WY; Chan, ASY; Ho, C; Ji, JF; Leung, SY; Chen, X
刊名CARCINOGENESIS
2006-03-01
DOI10.1093/carcin/bgi259
27期:3页:454-464
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]RECEPTOR TYROSINE KINASE ; DOWN-REGULATION ; BETA-CATENIN ; CANCER ; CARCINOMA ; MIGRATION ; FAMILY ; APC ; IDENTIFICATION ; TUMORIGENESIS
英文摘要

EphB2, a receptor tyrosine kinase regulated by the beta-catenin/Tcf4 complex, is expressed in the proliferative compartment of mouse intestine and regulates bidirectional migration of intestinal precursor cells in the crypt-villus axis through repulsive interaction with Ephrin-B ligands. Recently, it has been shown that reduction of EphB activity accelerates colon tumour progression in the Apc(Min/+) mice. In this study, we examined the expression of EphB2 in normal colon, adenomas, primary colorectal cancers (CRCs), lymph node metastases and liver metastases using immunohistochemistry on tissue microarrays. In addition, EphB2 was overexpressed in SW480 colon cancer cells to study its effect in vitro. We found that EphB2 was expressed in 100% of normal colon crypt base cells, 78% of adenomas, 55.4% of primary CRCs, 37.8% of lymph node metastases and 32.9% of liver metastases (all differences were statistically significant at P < 0.001 compared with primary CRCs). Patients with CRCs that lose EphB2 expression had more advanced tumour stage (P = 0.005), poor differentiation (P < 0.001), poor overall survival (P = 0.005) and disease-free survival (P = 0.001), with the latter being independent of tumour stage. In vitro studies showed that overexpression of EphB2 inhibited colon cancer cell growth in colony formation assay and activation of EphB2 receptor inhibited colon cancer cell adhesion and migration. Our data demonstrated a progressive loss of EphB2 expression in each critical step of colon carcinogenesis, including the onset of invasion, dedifferentiation and metastasis which are paralleled by adverse patient outcome. EphB2 may achieve its tumour suppressor function through regulation of cell survival, adhesion and migration.

语种英语
WOS记录号WOS:000235771300011
引用统计
被引频次:81[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65926
专题北京大学临床肿瘤学院
作者单位1.Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
2.Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
3.Peking Univ, Beijing Canc Hosp, Dept Surg, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Guo, DL,Zhang, J,Yuen, ST,et al. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours[J]. CARCINOGENESIS,2006,27(3):454-464.
APA Guo, DL.,Zhang, J.,Yuen, ST.,Tsui, WY.,Chan, ASY.,...&Chen, X.(2006).Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.CARCINOGENESIS,27(3),454-464.
MLA Guo, DL,et al."Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours".CARCINOGENESIS 27.3(2006):454-464.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Guo, DL]的文章
[Zhang, J]的文章
[Yuen, ST]的文章
百度学术
百度学术中相似的文章
[Guo, DL]的文章
[Zhang, J]的文章
[Yuen, ST]的文章
必应学术
必应学术中相似的文章
[Guo, DL]的文章
[Zhang, J]的文章
[Yuen, ST]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。